
|Articles|December 1, 2017
- Pharmaceutical Executive-12-01-2017
- Volume 37
- Issue 12
Pharmaceutical Executive, December 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Global Health: Fighting the Good Fightalmost 8 years ago
Global Health: Partnerships Hold the Keyalmost 8 years ago
First Foray into Digital Adherencealmost 8 years ago
Global Health: Messages of Hopealmost 8 years ago
A Year of Transformation for Science & Medicinealmost 8 years ago
Access and Reimbursement for Adoptive T-Cell Transfer Drugsalmost 8 years ago
Will Europe Turn a Corner in Personalized Medicine?almost 8 years ago
Fulfilling the Vision of Science: AstraZeneca's Ruud Dobberalmost 8 years ago
Country Report: CanadaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
2
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
3
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
4
Advancing Neuroscience and Rare Disease Innovation
5